How to Navigate the Evolving Job Landscape with Confidence
January 21, 2026
World’s Most Followed TikToker Khaby Lame Lands Historic $900M Creator Economy Deal
January 26, 2026
PraxisPro, a data intelligence company rebuilding the fractured state of Life Sciences, has announced the close of its oversubscribed $6 million seed round.
AlleyCorp led the funding, with additional investors including Flybridge, South Loop Ventures, Zeal Capital Partners, True Ventures, Techstars, Alumni Ventures, and Daring Ventures.
The new cash injection will help the startup improve the core platform and grow the team to support the growing number of customers.
Related Post: Crystal Brown’s CircNova Raises $3.3M to Accelerate Development of RNA Therapeutics
How PraxisPro Started and Works
PraxisPro launched in 2023 after Cam Badger’s struggle in sales, where he began his career at a pharmaceutical company. Rather than finding structure and mentorship on the job, he found “fragmented training, inconsistent coaching, and no real way to scale learning in a meaningful way,” he told TechCrunch.
He spent four years as a sales rep, then a sales trainer, and then worked for a medical startup where he met Dr. Benny Alouf. The two lamented how poor many sales reps were at life science companies, such as pharma and medical device startups.
In addition, these companies rely on disconnected, incomplete, and often undocumented data with their customers to make critical commercial decisions. This often creates avoidable compliance risks and missed opportunities to improve patient outcomes.
The duo, alongside Bhrugu Giri, decided to fix this by launching PraxisPro, a sales-coaching platform for the medical field. They believe better salespeople will help get more treatments to doctors, ultimately helping patients.
“When commercial interactions with healthcare providers are ineffective, patients don’t get a fair shot at therapies that could meaningfully change their lives,” Badger, the startup’s CEO, said.
PraxisPro is a standalone platform that can be integrated into enterprise software. It develops small language models trained on life science data, helping companies navigate nuances when interacting with healthcare providers. The company has created an AI agent helping sales teams practice communication skills before engaging customers.
Related Post: Meet the FemTech Founder who Turned a Health Tragedy into Purpose
Badger said communication is critical in medical sales, where compliance is key. Companies are responsible for ensuring sales messaging aligns with legal frameworks. PraxisPro helps train sales reps to stay compliant and to educate them on communicating patient needs with healthcare providers.
How PraxisPro is Helping Life Sciences Organizations Address Rising Training Costs
Furthermore, the startup is enabling previously inaccessible datasets to be accessible via purpose-built Small Language Models (SLMs) and AI Agents designed for therapeutic areas and disease states.
“As a former sales professional, training leader, and commercial operator, we’re building the products I wish I had in every role I held,” said Cam Badger, Founder and CEO of PraxisPro. “By using curated, purpose-built SLMs, we’re helping Life Sciences teams generate the new data and insight they need to operate better, and ultimately make a greater difference for patients who rely on them.”
Through its Learning Experience Platform (LXP), PraxisPro enables Life Science organizations to address rising training costs driven by regulatory requirements, declining HCP engagement, and gaps in pre-call planning, post-call insights, and out-of-territory education. This provides a clearer picture of field activities and improvement opportunities without added operational burden.
Life Sciences organizations usually seek to improve patient outcomes with a more reliable, governed approach to commercial intelligence, reducing cost, complexity, and compliance risk.
Although there are other AI role-playing tools (like Quantified and SmartWinnr), Badger says his is different because his company is trained on smaller datasets and specifically focuses on the life sciences sector.
The oversubscribed seed round was led by Alley Corp, with additional investors such as Flybridge, South Loop Ventures, Zeal Capital Partners, True Ventures, Techstars, Alumni Ventures, and Daring Ventures.
Related Post: Michael Jordan Donates $10 million to Novant Health
“PraxisPro is applying AI in a way that is truly native to Life Sciences. Purpose-built models, governed data, and a deep understanding of real commercial workflows make this platform and this team uniquely positioned to lead the category,” said Omar Njie, Principal at AlleyCorp.
PraxisPro plans to invest the new funding into improving the core platform. This includes streamlined therapeutic-area and disease-state SLMs, enhanced mobile and self-service experiences, and growing the team to support its expanding customer base.
